Questions discussed in this category
	
        	
	
	Especially in the setting of these being more narrow acting than tofacitinib, should we consider them safer than our old drugs?
 
 
2207612797
 
Papers discussed in this category
	Circulation. Cardiovascular interventions, 2012-04